CHCWM – Cancer & Hematology Centers of West Michigan

Sanofi (CARMEN-LC03)

Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel in Previously Treated metastatic non-squamous Non-Small Cell Lung Cancer patients with CEACAM5 positive tumors

Principal Investigator: Dr. Eric Santos

For more information on this trial, read its profile on clinicaltrials.gov here.